Sort by
Refine Your Search
-
Listed
-
Field
-
design of allosteric modulators. You will work on developing design principles of targeted protein degradation in collaboration with Pharma. For more information on Dr. Vaidehi’s lab please visit here .
-
information about Dr. John Carpten’s research, please visit here. Your qualifications should include: Ph.D. degree in life or biomedical sciences, or a related discipline is required. Proven track record
-
, 2025), Science Immunology (2023, 2024), Molecular Cell (2025), Cancer Discovery (2019), JEM, PNAS, and Trends in Immunology. Dr. Ma’s research has been recognized with multiple national and institutional
-
physiology and pathogenesis. 2) Development of novel drugs to treat MASH, diabetes, and cancer. For more information on Dr. Wendong Huang’s research, please visit here . Your qualifications should include
-
, shaping the future of medicine through cutting-edge research. The laboratories of Dr. Le Xuan Truong Nguyen in the Department of Hematological Malignancies and Translational Sciences are seeking a highly
-
Biophysical methods (SPR, ITC, structural biology) o Antibody or scaffold display technologies · Track record of first-author publications in peer-reviewed journals · Strong data-analysis
-
-omics data to identify therapeutic targets and biomarkers. Study cardiomyopathy across models of diabetes, cancer, and pressure overload. Collaborate in an interdisciplinary team and contribute to high
-
in analyzing metabolomics and/or proteomics data. Prior wet lab experience with mass spectrometry, analytical chemistry, high-throughput sequencing library preparation, sequencing project planning and
-
Medicine, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug
-
to load any pages, check your computer’s network connection. If your computer or network is protected by a firewall or proxy, make sure that Firefox is permitted to access the web. If you continue, a third